-
MATTERHORN, ATOMIC, CHALLENGE, and More
Dr. Weinberg recaps key gastrointestinal cancer highlights from the 2025 ASCO Annual Meeting.
Category: News
-
Discover how genetic testing can help identify these rare treatment targets
New Lombardi research shows that a safe and effective targeted therapy can slow tumor growth in patients with some types of pancreatic and lung cancers.
Category: News
-
EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer
Dr. Weinberg discusses promising early results from the EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer.
Category: News
-
Excersise and Colorectal Cancer
Dr. Weinberg discussing exercise post-adjuvant chemotherapy for colorectal cancer with Fox5 DC
Category: News
-
Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib:
Dr. Weinberg Discusses Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib
Category: News
-
‘Bad’ Gut Bacteria Tied to Colorectal Cancer in Younger Adults
Dr. Marshall discusses how certain strains of E. coli bacteria during childhood may help explain soaring rates of colorectal cancer
Category: News
-
Dr. Marshall Discusses Targeted Therapy for CRC
John L. Marshall, MD, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.
Category: News
-
To be young, gifted and…healthy: The new face of colon cancer survivors
Dr. Noel discusses the rise of early onset GI Cancer in the Black Community
Category: News
-
New Treatments Give Hope to Patients With One of the Deadliest Cancers
Dr. Benjamin Weinberg is interviewed along with other GI Oncologists sharing discussing research innovations in Pancreatic Cancers.
Category: News
-
John Marshall Unscripted: The Economics of Cancer Care and Inflation Reduction Act Ripple Effect
Dr. Marshall delves into the complex economics of cancer care in early 2025.
Category: News